Budgetary Impact Of Intravitreal Aflibercept Injection (IAI) In Treating Neovascular Age-Related Macular Degeneration In A US Health Plan Of Adults Ages 65 Years And Older
Abstract
Authors
R. Vitti K.M. Clements H. Panchmatia E. Hulbert K. Wittrup-Jensen B.E. Lewis